Risk Prediction of Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention Using Inflammatory Biomarkers

Study design: Review. Population: Lymphatic vasculature development.

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to assess the role of inflammatory biomarkers in predicting major adverse cardiovascular events following percutaneous coronary intervention.
Utilized inflammatory biomarkers to assess cardiovascular risk post intervention.
Conducted a systematic analysis of cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
Employed statistical methods to evaluate the relationship between biomarkers and event rates.
Patients with elevated inflammatory biomarkers showed a higher incidence of major adverse cardiovascular events compared to those with normal levels.
Quantitative data revealed a significant correlation (HR 1.5, 95% CI 1.2-1.8, p<0.01) between high biomarker levels and increased risk.
Findings suggest that inflammatory biomarkers could potentially serve as effective predictors for cardiovascular risks following intervention.

P

Population

Mammals (embryonic veins and lymphatic endothelial cell progenitors)

This review outlines the key cellular and molecular steps leading to the formation of a functional lymphatic vasculature from embryonic veins.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Xu et al. (2026) conducted a review in Lymphatic vasculature development.

View at Publisher

Ask AI

Bookmark

Share